Business Context and Reporting Period
Company: NOVONIX Ltd (Foreign Private Issuer)
Filing Type: Form 6-K
Reporting Period: Month of December 2025
Filing Date: December 4, 2025
Principal Executive Office: Level 38, 71 Eagle Street, Brisbane, QLD 4000, Australia
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This Form 6-K serves as a notification of a corporate action rather than a financial results report.
Material Changes
The primary material event disclosed is the cessation of securities, as detailed in the attached Exhibit 99.1 (Appendix 3H) dated December 3, 2025.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items beyond the notification of the cessation of securities.
Investor Verification Checklist
- Verify the specific details of the "cessation of securities" referenced in Exhibit 99.1 (Appendix 3H).
- Confirm the impact of the cessation on the company's capital structure and share registry.
- Review the official notification dated December 3, 2025, for any conditions or effective dates associated with the cessation.